The Bob Harrington Show - Episode 28: AVERROES: Apixaban as a future alternative to warfarin with Dr Stuart Connolly

Summary: The findings of the AVERROES trial foretell a future with appropriate treatment for patients with atrial fibrillation who are not candidates for anticoagulation with oral vitamin-K antagonists. In this discussion, Dr Stuart Connolly describes the design and findings of this important trial, the safety and efficacy data for apixaban, and shares his predictions for better anticoagulation options for this patient set. What are your thoughts on apixaban as a future alternative to warfarin?